Cell treatment with TAT-MP1Gly peptide, which stabilizes the mitofusin conformation state, enhanced the mitophagy pathway in HF hearts and prevented giant Parkin-rich fusion formation without a significant effect in age matched control hearts. The gene discussed is PRKN; the disease is hydrops fetalis.